Cranial, Renal, and Skeletal Anomalies in a Fetus With a Pathogenic Variant in the TAFAZZIN Gene. [PDF]
Muir CR, Gilmore KL, Singh S, Vora NL.
europepmc +1 more source
Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. [PDF]
Sabbah HN +8 more
europepmc +1 more source
Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts. [PDF]
PiƱeiro-Llanes J +8 more
europepmc +1 more source
ECG Findings Are Poor Predictors for Adverse Events and Cardiac Death in Barth Syndrome. [PDF]
Hutchinson A +3 more
europepmc +1 more source
State of the industry: integration of 3Rs principles and new approach methodologies in non-clinical product development through fit-for-purpose. [PDF]
Poppenborg SM, Webster DA, Carlsson B.
europepmc +1 more source
Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. [PDF]
Yu J +7 more
europepmc +1 more source
Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts. [PDF]
Mejia EM +3 more
europepmc +1 more source
Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome. [PDF]
Sniezek Carney O +8 more
europepmc +1 more source
Sensor-based digital health technologies to capture endpoints in recent clinical trials: a scoping review. [PDF]
Garcia J +7 more
europepmc +1 more source
The Pharmaceutical Industry in 2025: An Analysis of FDA Drug Approvals from the Perspective of Molecules. [PDF]
de la Torre BG, Albericio F.
europepmc +1 more source

